A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC) (PROTECT-3)

Trial Details

  • 510 patients will be taking part in this study
  • Condition: Ulcerative Colitis
  • Intervention: Drug: LT-02 Drug: LT-02 Placebo
  • Clinic: GI Research Institute Suite 770-1190 Hornby Street, Vancouver, British Columbia, Canada


The purpose of this study is to determine whether Phosphatidylcholine (LT-02) add on treatment is effective and safe for the induction of remission in ulcerative colitis patients refractory to standard treatment with mesalamine.


Brian bressler headshot for dt trial listings

Full Trial Details